Details for Patent: 11,597,699
✉ Email this page to a colleague
Which drugs does patent 11,597,699 protect, and when does it expire?
Patent 11,597,699 protects COTELLIC and is included in one NDA.
This patent has sixty-six patent family members in thirty-two countries.
Summary for Patent: 11,597,699
| Title: | MEK inhibitors and methods of their use |
| Abstract: | Disclosed are compounds of Formula (I) and pharmaceutically acceptable salts and solvates thereof. Such compounds are MEK inhibitors and are useful in the treatment of proliferative diseases, such as cancer. Also disclosed are pharmaceutical compositions containing such compounds as well as methods of using the compounds and compositions of the invention in the treatment of cancer. |
| Inventor(s): | Naing Aay, Neel Kumar Anand, Charles M. Blazey, Owen Joseph Bowles, Joerg Bussenius, Simona Costanzo, Jeffry Kimo Curtis, Steven Charles Defina, Larisa Dubenko, Anagha Abhijit Joshi, Abigail R. Kennedy, Angie Inyoung Kim, Elena S. Koltun, Jean-Claire Limun Manalo, Csaba J. Peto, Kenneth D. Rice, Tsze H. Tsang |
| Assignee: | Exelixis Inc |
| Application Number: | US16/853,043 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 11,597,699
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech Inc | COTELLIC | cobimetinib fumarate | TABLET;ORAL | 206192-001 | Nov 10, 2015 | RX | Yes | Yes | 11,597,699 | ⤷ Start Trial | AS A SINGLE AGENT FOR THE TREATMENT OF ADULT PATIENTS WITH HISTIOCYTIC NEOPLASMS | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,597,699
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1934174 | ⤷ Start Trial | 300809 | Netherlands | ⤷ Start Trial |
| European Patent Office | 1934174 | ⤷ Start Trial | C20160012 00193 | Estonia | ⤷ Start Trial |
| European Patent Office | 1934174 | ⤷ Start Trial | PA2016016 | Lithuania | ⤷ Start Trial |
| European Patent Office | 1934174 | ⤷ Start Trial | 93078 | Luxembourg | ⤷ Start Trial |
| European Patent Office | 1934174 | ⤷ Start Trial | CA 2016 00021 | Denmark | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
